Tourmaline Bio Inc [TRML] stock prices are up 2.58% to $17.11 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The TRML shares have gain 11.68% over the last week, with a monthly amount drifted -4.15%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tourmaline Bio Inc [NASDAQ: TRML] stock has seen the most recent analyst activity on April 23, 2025, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $70. Previously, Wedbush started tracking the stock with Outperform rating on March 06, 2025, and set its price target to $42. On December 06, 2024, BMO Capital Markets initiated with a Outperform rating and assigned a price target of $50 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $49 on November 11, 2024. Jefferies initiated its recommendation with a Buy and recommended $41 as its price target on December 15, 2023. In a note dated November 17, 2023, Truist initiated an Buy rating and provided a target price of $43 on this stock.
The stock price of Tourmaline Bio Inc [TRML] has been fluctuating between $11.56 and $29.79 over the past year. Currently, Wall Street analysts expect the stock to reach $47.33 within the next 12 months. Tourmaline Bio Inc [NASDAQ: TRML] shares were valued at $17.11 at the most recent close of the market. An investor can expect a potential return of 176.62% based on the average TRML price forecast.
Analyzing the TRML fundamentals
Gross Profit Margin for this corporation currently stands at 0.25% with Operating Profit Margin at -2461.15%, Pretax Profit Margin comes in at -2071.72%, and Net Profit Margin reading is -2071.72%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.27 and Total Capital is -0.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.33 points at the first support level, and at 15.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.94, and for the 2nd resistance point, it is at 18.78.
Ratios To Look Out For
It’s worth pointing out that Tourmaline Bio Inc [NASDAQ:TRML]’s Current Ratio is 33.87. On the other hand, the Quick Ratio is 33.87, and the Cash Ratio is 4.64.
Transactions by insiders
Recent insider trading involved Kulkarni Sandeep Chidambar, CEO, that happened on Aug 21 ’24 when 1779.0 shares were purchased. CEO, Kulkarni Sandeep Chidambar completed a deal on Aug 16 ’24 to buy 5221.0 shares.
